No | Population | Male fraction | Average age at start of follow-up | Average age at end of follow-up | Dose quantity | ERR per dose (Gy−1) in LSS, βlss, best estimate and 90% CI | Risk ratio, q, best estimate and 90% CI |
1 | Workers at Rocketdyne | 0.92 | 31 | 56 | Skin dose | 0.26 (0.16 to 0.35)* | 0.00 (−7.25 to 7.33) |
2 | Radiation workers in nuclear industry | 0.90 | 31 | 46 | Colon dose | 0.49 (0.30 to 0.67) | 1.19 (−0.34 to 3.12) |
3 | Chernobyl clean-up workers† | 1.00 | 35 | 47 | Skin dose | 0.47 (0.29 to 0.65)* | 4.49 (2.79 to 7.17) |
4 | Chernobyl clean-up workers | 1.00 | 35 | 50 | Skin dose | 0.23 (0.11 to 0.34)* | 6.66 (1.67 to 14.7) |
5 | Techa River residents‡ | 0.40 | 28 | 63 | Stomach dose | 0.54 (0.42 to 0.65)* | 1.71 (0.52 to 3.04) |
6 | UK radiation workers | 0.90 | 29 | 52 | Skin dose | 0.30 (0.21 to 0.39) | 0.91 (0.01 to 2.01) |
7 | ORNL workers | 1.00 | 30 | 57 | Skin dose | 0.25 (0.16 to 0.33) | 19.6 (−6.38 to 51.3) |
8 | French nuclear workers | 0.79 | 31 | 49 | Skin dose | 0.33 (0.23 to 0.43) | 4.59 (−2.34 to 12.6) |
9 | Hanford workers | 0.76 | 31 | 55 | Skin dose | 0.41 (0.33 to 0.49) | 0.73 (−0.87 to 2.35) |
ORNL, Oak Ridge National Laboratory.
*95% confidence interval.
†Calculations performed for all cancer, because out of 515 neoplasms (ICD-9 140–239) there were only three non-cancer cases (ICD-9 208–239).
‡Calculations performed for all solid cancer, because mortality data with DS02 were not available for bone cancer.